ON THE MECHANISM OF ACTION OF KETANSERIN, A SELECTIVE ANTAGONIST OF THE S-2 RECEPTORS WITH ANTIHYPERTENSIVE ACTIVITY

被引：0
|
作者：
RION, R
MENA, MA
HONG, E
机构：
来源：
PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY | 1983年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：373 / 375
页数：3
相关论文
共 50 条
  • [31] CHARACTERIZATION AND REGIONAL DISTRIBUTION OF SEROTONIN S-2 RECEPTORS IN HUMAN-BRAIN
    SCHOTTE, A
    MALOTEAUX, JM
    LADURON, PM
    BRAIN RESEARCH, 1983, 276 (02) : 231 - 235
  • [32] THE EFFECT OF A SELECTIVE 5-HT2 ANTAGONIST, KETANSERIN, ON THE PULMONARY RESPONSES TO ESCHERICHIA-COLI ENDOTOXIN
    BALL, HA
    PARRATT, JR
    RODGER, IW
    BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (02) : 295 - 301
  • [33] SEROTONIN-S2 RECEPTORS AND MIGRAINE - A STUDY WITH THE SELECTIVE ANTAGONIST ICI 169,369
    DAVIES, PTG
    STEINER, TJ
    HEADACHE, 1990, 30 (06): : 340 - 343
  • [34] THE ACUTE AND CHRONIC ANTIHYPERTENSIVE EFFECTS OF KETANSERIN CANNOT BE EXPLAINED BY BLOCKADE OF VASCULAR SEROTONIN, TYPE-2, RECEPTORS OR ALPHA-1-ADRENERGIC RECEPTORS
    BLAUW, GJ
    VANBRUMMELEN, P
    DOORENBOS, CJ
    VANDERVELDE, EA
    VANZWIETEN, PA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) : 377 - 384
  • [35] EFFECT OF THE SELECTIVE 5-HT2 ANTAGONIST KETANSERIN ON ADENOSINE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTS
    CAZZOLA, M
    MATERA, MG
    SANTANGELO, G
    ASSOGNA, G
    DAMATO, G
    ROSSI, F
    GIRBINO, G
    IMMUNOPHARMACOLOGY, 1992, 23 (01): : 21 - 28
  • [36] HEMORHEOLOGICAL EFFECTS OF KETANSERIN, A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, IN AGED, SPONTANEOUSLY HYPERTENSIVE DOGS
    DECLERCK, F
    JAGENEAU, A
    DOM, J
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1982, 258 (01): : 100 - 115
  • [37] EFFECT OF KETANSERIN, AN INHIBITOR OF 5-HT2 RECEPTORS, ON THE ALDOSTERONE-STIMULATING ACTION OF METOCLOPRAMIDE
    UBERTI, ECD
    TRASFORINI, G
    MARGUTTI, AR
    ROTOLA, CA
    BIANCONI, M
    PANSINI, P
    HORMONE RESEARCH, 1983, 17 (03) : 160 - 167
  • [38] EXPERIENCE WITH KETANSERIN, A SEROTONIN (S2) ANTAGONIST, IN LONGTERM TREATMENT OF ESSENTIAL-HYPERTENSION
    HEDNER, T
    PERSSON, B
    BERGLUND, G
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1984, 6 (03) : 743 - 751
  • [39] VASCULAR EFFECTS OF KETANSERIN (R-41-468), A NOVEL ANTAGONIST OF 5-HT2 SEROTONERGIC RECEPTORS
    VANNUETEN, JM
    JANSSEN, PAJ
    VANBEEK, J
    XHONNEUX, R
    VERBEUREN, TJ
    VANHOUTTE, PM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1981, 218 (01): : 217 - 230
  • [40] INVESTIGATION OF SEROTONIN RECEPTORS IN THE ADRENAL ZONA GLOMERULOSA USING KETANSERIN, A SPECIFIC 5HT2 RECEPTOR ANTAGONIST
    WILLIAMS, BC
    SHAIKH, S
    CARR, P
    EDWARDS, CRW
    SCOTTISH MEDICAL JOURNAL, 1983, 28 (02) : 194 - 194
12345